Trial Profile
A Study of Reducing the Symptom Burden Produced by Chemoradiation Treatment for Head and Neck Cancer.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary) ; Bupropion (Primary) ; Minocycline (Primary) ; Curcumin
- Indications Anorexia; Deglutition disorders; Fatigue; Pain; Sleep disorders
- Focus Therapeutic Use
- 23 Mar 2013 New source identified and integrated (M.D. Anderson Cancer Center: 2009-0517).
- 21 Mar 2013 Planned End Date changed from 1 Jul 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 08 Mar 2013 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.